170 related articles for article (PubMed ID: 36691128)
1. Prognostic value of FOXP3
Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M
BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of Forkhead box P3 regulatory T cells in biliary tract cancer: A systematic review and meta-analysis.
Cai P; Wu Z; Yang X; Wang N; Yang Y
Medicine (Baltimore); 2023 Dec; 102(50):e36608. PubMed ID: 38115302
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
Hu L; Zhu M; Shen Y; Zhong Z; Wu B
World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis.
Peng F; Qin Y; Mu S; Li J; Ai L; Hu Y
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3123-3135. PubMed ID: 32995955
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
6. High levels of Tim-3
Zhong W; Liu X; Zhu Z; Li Q; Li K
Int Immunopharmacol; 2021 Jul; 96():107662. PubMed ID: 33864956
[TBL] [Abstract][Full Text] [Related]
7. Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma.
Chang C; Chen YP; Medeiros LJ; Chen TY; Chang KC
Leuk Lymphoma; 2021 Jan; 62(1):76-85. PubMed ID: 32962457
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma.
Serag El-Dien MM; Abdou AG; Asaad NY; Abd El-Wahed MM; Kora MAEM
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):534-542. PubMed ID: 26862953
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis.
Lee NR; Song EK; Jang KY; Choi HN; Moon WS; Kwon K; Lee JH; Yim CY; Kwak JY
Leuk Lymphoma; 2008 Feb; 49(2):247-56. PubMed ID: 18231910
[TBL] [Abstract][Full Text] [Related]
10. The prognostic values of FOXP3
Sun Y; Wang Y; Lu F; Zhao X; Nie Z; He B
Clin Transl Oncol; 2023 Jun; 25(6):1830-1843. PubMed ID: 36692642
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and function of CD4
Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
[TBL] [Abstract][Full Text] [Related]
12. Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.
Stirm K; Leary P; Wüst D; Stark D; Joller N; Karakus U; Boyman O; Tzankov A; Müller A
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822670
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.
Shou J; Zhang Z; Lai Y; Chen Z; Huang J
BMC Cancer; 2016 Aug; 16(1):687. PubMed ID: 27566250
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified.
Nakayama S; Yokote T; Akioka T; Hiraoka N; Nishiwaki U; Miyoshi T; Iwaki K; Takayama A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Blood Adv; 2017 Mar; 1(8):486-493. PubMed ID: 29296965
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
[TBL] [Abstract][Full Text] [Related]
17. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
Hasselblom S; Sigurdadottir M; Hansson U; Nilsson-Ehle H; Ridell B; Andersson PO
Br J Haematol; 2007 May; 137(4):364-73. PubMed ID: 17456059
[TBL] [Abstract][Full Text] [Related]
18. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells.
Vaughan JW; Shi M; Horna P; Olteanu H
Ann Diagn Pathol; 2020 Oct; 48():151585. PubMed ID: 32829067
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
20. The Clinicopathological and Prognostic Implications of FoxP3
Xu P; Fan W; Zhang Z; Wang J; Wang P; Li Y; Yu M
Front Physiol; 2017; 8():950. PubMed ID: 29209232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
